Anixa Biosciences Inc

-0.13 (-3.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Anixa Biosciences Inc Stock, NASDAQ:ANIX

3150 Almaden Expressway, Suite 250, San Jose, California 95118
United States of America
Phone: +1.408.708.9808
Number of Employees: 4


Anixa Biosciences, Inc. is a cancer-focused biotechnology company, which focuses on harnessing the bodyâ??s immune system in the fight against cancer. It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the bodyâ??s immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immune-therapy drugs which genetically engineer a patientâ??s own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.